Abonnement à la biblothèque: Guest
Critical Reviews™ in Oncogenesis

Publication de 4  numéros par an

ISSN Imprimer: 0893-9675

ISSN En ligne: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Dendritic Cell Editing by Natural Killer Cells

Volume 19, Numéro 1-2, 2014, pp. 67-75
DOI: 10.1615/CritRevOncog.2014010827
Get accessGet access

RÉSUMÉ

Activated, mature, dendritic cells (DCs) are the main antigen-presenting cells for initiating adaptive immune responses, whereas immature DCs have been implicated in tolerance and induction of regulatory T cells. It is now well established that NK cells are able to discriminate between mature and immature DCs by killing the latter because of their low amount of surface human leukocyte antigen (HLA) class I molecules. Thus, NK cells are thought to play an important regulatory role by selectively editing DCs during the course of immune responses. NK-mediated killing of immature (but not mature) DCs results in selection of immunogenic DCs during the initiation of anti-cancer immune responses. In addition to the removal of inappropriate DCs, NK cells can also shape adaptive immune responses by promoting DC maturation and influencing the polarization of primary T-cell responses. DC-NK cell interactions should be carefully considered in DC-based cancer vaccine strategies. Optimal NK cell activation should be sought to enhance the magnitude and the quality of both innate and adaptive immune responses against tumors.

CITÉ PAR
  1. Finocchiaro Gaetano, Pellegatta Serena, Perspectives for immunotherapy in glioblastoma treatment, Current Opinion in Oncology, 26, 6, 2014. Crossref

  2. El-Ashmawy N.E., El-Zamarany E.A., Salem M.L., El-Bahrawy H.A., Al-Ashmawy G.M., In vitro and in vivo studies of the immunomodulatory effect of Echinacea purpurea on dendritic cells, Journal of Genetic Engineering and Biotechnology, 13, 2, 2015. Crossref

  3. Horton Nathan C., Mathew Porunelloor A., NKp44 and Natural Cytotoxicity Receptors as Damage-Associated Molecular Pattern Recognition Receptors, Frontiers in Immunology, 6, 2015. Crossref

  4. Bonaccorsi Irene, De Pasquale Claudia, Campana Stefania, Barberi Chiara, Cavaliere Riccardo, Benedetto Filippo, Ferlazzo Guido, Natural killer cells in the innate immunity network of atherosclerosis, Immunology Letters, 168, 1, 2015. Crossref

  5. Verma Chandan, Kaewkangsadan Viriya, Eremin Jennifer M, Cowley Gerard P, Ilyas Mohammad, El-Sheemy Mohamed A, Eremin Oleg, Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery, Journal of Translational Medicine, 13, 1, 2015. Crossref

  6. Oth Tammy, Van Elssen Catharina H.M.J., Schnijderberg Melanie C.A., Senden-Gijsbers Birgit L.M.G., Germeraad Wilfred T.V., Bos Gerard M.J., Vanderlocht Joris, Potency of Both Human Th1 and NK Helper Cell Activation is Determined by IL-12p70-Producing PAMP-Matured DCs, Journal of Interferon & Cytokine Research, 35, 9, 2015. Crossref

  7. Li Yan, Meng Fan-Dong, Tian Xin, Sui Cheng-Guang, Liu Yun-Peng, Jiang You-Hong, Impact of IL-2 and IL-2R SNPs on Proliferation and Tumor-killing Activity of Lymphokine-Activated Killer Cells from Healthy Chinese Blood Donors, Asian Pacific Journal of Cancer Prevention, 15, 18, 2014. Crossref

  8. Gardiner Clair M., NK cell function and receptor diversity in the context of HCV infection, Frontiers in Microbiology, 6, 2015. Crossref

  9. Land W. G., Agostinis P., Gasser S., Garg A. D., Linkermann A., Transplantation and Damage-Associated Molecular Patterns (DAMPs), American Journal of Transplantation, 16, 12, 2016. Crossref

  10. Cacalano Nicholas A., Regulation of Natural Killer Cell Function by STAT3, Frontiers in Immunology, 7, 2016. Crossref

  11. Pesce Silvia, Moretta Lorenzo, Moretta Alessandro, Marcenaro Emanuela, Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor, Frontiers in Immunology, 7, 2016. Crossref

  12. Hochnadel Inga, Kossatz-Boehlert Uta, Jedicke Nils, Lenzen Henrike, Manns Michael P., Yevsa Tetyana, Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers, Human Vaccines & Immunotherapeutics, 13, 12, 2017. Crossref

  13. López-Soto Alejandro, Gonzalez Segundo, Smyth Mark J., Galluzzi Lorenzo, Control of Metastasis by NK Cells, Cancer Cell, 32, 2, 2017. Crossref

  14. Pesce Silvia, Thoren Fredrik B., Cantoni Claudia, Prato Carola, Moretta Lorenzo, Moretta Alessandro, Marcenaro Emanuela, The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands, Frontiers in Immunology, 8, 2017. Crossref

  15. Rätsep Matthew T., Moore Stephen D., Jafri Salema, Mitchell Melissa, Brady Hugh J. M., Mandelboim Ofer, Southwood Mark, Morrell Nicholas W., Colucci Francesco, Ormiston Mark L., Spontaneous pulmonary hypertension in genetic mouse models of natural killer cell deficiency, American Journal of Physiology-Lung Cellular and Molecular Physiology, 315, 6, 2018. Crossref

  16. Sarhan Maysa, Land Walter G., Tonnus Wulf, Hugo Christian P., Linkermann Andreas, Origin and Consequences of Necroinflammation, Physiological Reviews, 98, 2, 2018. Crossref

  17. Flórez-Álvarez Lizdany, Hernandez Juan C., Zapata Wildeman, NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies, Frontiers in Immunology, 9, 2018. Crossref

  18. Land Walter Gottlieb, Antigen in the Presence of DAMPs Induces Immunostimulatory Dendritic Cells to Promote Destructive Adaptive Immune Responses, in Damage-Associated Molecular Patterns in Human Diseases, 2018. Crossref

  19. Ziblat Andrea, Nuñez Sol Y., Raffo Iraolagoitia Ximena Lucía, Spallanzani Raúl German, Torres Nicolás I., Sierra Jessica M., Secchiari Florencia, Domaica Carolina I., Fuertes Mercedes B., Zwirner Norberto W., Interleukin (IL)-23 Stimulates IFN-γ Secretion by CD56bright Natural Killer Cells and Enhances IL-18-Driven Dendritic Cells Activation, Frontiers in Immunology, 8, 2018. Crossref

  20. Lee Hansol, Quek Camelia, Silva Ines, Tasker Annie, Batten Marcel, Rizos Helen, Lim Su Yin, Nur Gide Tuba, Shang Ping, Attrill Grace H., Madore Jason, Edwards Jarem, Carlino Matteo S., Guminski Alexander, Saw Robyn P.M., Thompson John F., Ferguson Peter M., Palendira Umaimainthan, Menzies Alexander M., Long Georgina V., Scolyer Richard A., Wilmott James S., Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients, OncoImmunology, 8, 2, 2019. Crossref

  21. Pauza C. David, Liou Mei-Ling, Lahusen Tyler, Xiao Lingzhi, Lapidus Rena G., Cairo Cristiana, Li Haishan, Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local, Frontiers in Immunology, 9, 2018. Crossref

  22. Chiossone Laura, Dumas Pierre-Yves, Vienne Margaux, Vivier Eric, Natural killer cells and other innate lymphoid cells in cancer, Nature Reviews Immunology, 18, 11, 2018. Crossref

  23. Valdes-Mora Fatima, Handler Kristina, Law Andrew M. K., Salomon Robert, Oakes Samantha R., Ormandy Christopher J., Gallego-Ortega David, Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology, Frontiers in Immunology, 9, 2018. Crossref

  24. Li Yanchun, Yu Xiuhua, Ma Yucong, Hua Shucheng, IL-23 and dendritic cells: What are the roles of their mutual attachment in immune response and immunotherapy?, Cytokine, 120, 2019. Crossref

  25. Lhuillier Claire, Galluzzi Lorenzo, Preface: Dendritic cells: Master regulators of innate and adaptive immunity, in Immunobiology of Dendritic Cells Part B, 349, 2019. Crossref

  26. Lhuillier Claire, Galluzzi Lorenzo, Preface—Dendritic cells: Master regulators of innate and adaptive immunity, in Immunobiology of Dendritic Cells Part A, 348, 2019. Crossref

  27. Masselli Elena, Vaccarezza Mauro, Carubbi Cecilia, Pozzi Giulia, Presta Valentina, Mirandola Prisco, Vitale Marco, NK cells: A double edge sword against SARS-CoV-2, Advances in Biological Regulation, 77, 2020. Crossref

  28. Pierce Stephen, Geanes Eric S., Bradley Todd, Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response, Frontiers in Cellular and Infection Microbiology, 10, 2020. Crossref

  29. Ogawa-Ochiai Keiko, Katagiri Takamasa, Sato Yuki, Shirai Akiko, Ishiyama Ken, Takami Akiyoshi, Morishita Eriko, Natural killer cell function changes by the Japanese Kampo Medicine Juzentaihoto in General fatigue patients, Advances in Integrative Medicine, 8, 1, 2021. Crossref

  30. Davies Alexander J., Rinaldi Simon, Costigan Michael, Oh Seog Bae, Cytotoxic Immunity in Peripheral Nerve Injury and Pain, Frontiers in Neuroscience, 14, 2020. Crossref

  31. Stewart John H., Blazer Dan G., Calderon Maria Jose Godoy, Carter Taylor M., Eckhoff Austin, Al Efishat Mohammad A., Fernando Deemantha G., Foster Jason M., Hayes-Jordan Andrea, Johnston Fabian M., Lautz Timothy B., Levine Edward A., Maduekwe Ugwuji N., Mangieri Christopher W., Moaven Omeed, Mogal Harveshp, Shen Perry, Votanopoulos Konstantinos I., The Evolving Management of Peritoneal Surface Malignancies, Current Problems in Surgery, 58, 4, 2021. Crossref

  32. Su Tong, Zhang Panpan, Zhao Fujun, Zhang Shu, A novel immune-related prognostic signature in epithelial ovarian carcinoma, Aging, 13, 7, 2021. Crossref

  33. Bao Changqian, Tao Xiandong, Cui Wei, Hao Yuanyuan, Zheng Shuaike, Yi Bin, Pan Tiewen, Young Ken H., Qian Wenbin, Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients, Experimental Hematology & Oncology, 10, 1, 2021. Crossref

  34. Rea Irene Maeve, Alexander H. Denis, Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing, Ageing Research Reviews, 73, 2022. Crossref

  35. Woods Elena, Zaiatz-Bittencourt Vanessa, Bannan Ciaran, Bergin Colm, Finlay David K., Hoffmann Matthias, Brown Anthony, Turner Bethany, Makvandi-Nejad Shokouh, Vassilev Ventzi, Capone Stefania, Folgori Antonella, Hanke Tomáš, Barnes Eleanor, Dorrell Lucy, Gardiner Clair M., Specific human cytomegalovirus signature detected in NK cell metabolic changes post vaccination, npj Vaccines, 6, 1, 2021. Crossref

  36. Zhou Xin, Huang Jia-mi, Li Tian-man, Liu Jun-qi, Wei Zhong-liu, Lan Chen-lu, Zhu Guang-zhi, Liao Xi-wen, Ye Xin-ping, Peng Tao, Clinical Significance and Potential Mechanisms of ATP Binding Cassette Subfamily C Genes in Hepatocellular Carcinoma, Frontiers in Genetics, 13, 2022. Crossref

  37. Finzel Stephanie, Voll Reinhard E., On the Complex Pathogenesis of Sjögren’s Syndrome: Salivary Gland Epithelial Cells and Cells of the Innate and Adaptive Immune System, in Sjögren’s Syndrome and the Salivary Glands, 2022. Crossref

  38. Li Joey H., O’Sullivan Timothy E., Back to the Future: Spatiotemporal Determinants of NK Cell Antitumor Function, Frontiers in Immunology, 12, 2022. Crossref

  39. Liu Hao, Wang Zi-Ying, Zhou Yu-Cong, Song Wei, Ali Usman, Sze Daniel M.-Y, Immunomodulation of Chinese Herbal Medicines on NK cell populations for cancer therapy: A systematic review, Journal of Ethnopharmacology, 268, 2021. Crossref

  40. Lindsay Robin S., Melssen Marit M., Stasiak Katarzyna, Annis Jessica L., Woods Amber N., Rodriguez Anthony B., Brown Michael G., Engelhard Victor H., NK cells reduce anergic T cell development in early-stage tumors by promoting myeloid cell maturation, Frontiers in Oncology, 12, 2022. Crossref

Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain